243 related articles for article (PubMed ID: 23630294)
1. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.
Stratinaki M; Varidaki A; Mitsi V; Ghose S; Magida J; Dias C; Russo SJ; Vialou V; Caldarone BJ; Tamminga CA; Nestler EJ; Zachariou V
Proc Natl Acad Sci U S A; 2013 May; 110(20):8254-9. PubMed ID: 23630294
[TBL] [Abstract][Full Text] [Related]
2. RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine.
Mitsi V; Ruiz A; Polizu C; Farzinpour Z; Ramakrishnan A; Serafini RA; Parise EM; Floodstrand M; Sial OK; Gaspari S; Tang CY; Nestler EJ; Schmidt EF; Shen L; Zachariou V
Mol Pharmacol; 2024 Mar; 105(4):272-285. PubMed ID: 38351270
[TBL] [Abstract][Full Text] [Related]
3. The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.
Dripps IJ; Wang Q; Neubig RR; Rice KC; Traynor JR; Jutkiewicz EM
Psychopharmacology (Berl); 2017 Jan; 234(1):29-39. PubMed ID: 27624599
[TBL] [Abstract][Full Text] [Related]
4. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.
Han MH; Renthal W; Ring RH; Rahman Z; Psifogeorgou K; Howland D; Birnbaum S; Young K; Neve R; Nestler EJ; Zachariou V
Biol Psychiatry; 2010 Apr; 67(8):761-9. PubMed ID: 19914603
[TBL] [Abstract][Full Text] [Related]
5. RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.
Mitsi V; Terzi D; Purushothaman I; Manouras L; Gaspari S; Neve RL; Stratinaki M; Feng J; Shen L; Zachariou V
Proc Natl Acad Sci U S A; 2015 Sep; 112(36):E5088-97. PubMed ID: 26305935
[TBL] [Abstract][Full Text] [Related]
6. Regulator of G-Protein Signaling 4 (RGS4) Controls Morphine Reward by Glutamate Receptor Activation in the Nucleus Accumbens of Mouse Brain.
Kim J; Lee S; Kang S; Jeon TI; Kang MJ; Lee TH; Kim YS; Kim KS; Im HI; Moon C
Mol Cells; 2018 May; 41(5):454-464. PubMed ID: 29754475
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2.
D'Souza MS; Seeley SL; Emerson N; Rose-Malkamaki MJ; Ho SP; Tsai YC; Kuo H; Huan CY; Rorabaugh BR
Pharmacol Biochem Behav; 2022 Feb; 213():173338. PubMed ID: 35038444
[TBL] [Abstract][Full Text] [Related]
8. RGS4 Maintains Chronic Pain Symptoms in Rodent Models.
Avrampou K; Pryce KD; Ramakrishnan A; Sakloth F; Gaspari S; Serafini RA; Mitsi V; Polizu C; Swartz C; Ligas B; Richards A; Shen L; Carr FB; Zachariou V
J Neurosci; 2019 Oct; 39(42):8291-8304. PubMed ID: 31308097
[TBL] [Abstract][Full Text] [Related]
9. RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling.
Jaén C; Doupnik CA
J Biol Chem; 2006 Nov; 281(45):34549-60. PubMed ID: 16973624
[TBL] [Abstract][Full Text] [Related]
10. A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.
Kremer M; Yalcin I; Goumon Y; Wurtz X; Nexon L; Daniel D; Megat S; Ceredig RA; Ernst C; Turecki G; Chavant V; Théroux JF; Lacaud A; Joganah LE; Lelievre V; Massotte D; Lutz PE; Gilsbach R; Salvat E; Barrot M
J Neurosci; 2018 Nov; 38(46):9934-9954. PubMed ID: 30249798
[TBL] [Abstract][Full Text] [Related]
11. Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay.
Storaska AJ; Mei JP; Wu M; Li M; Wade SM; Blazer LL; Sjögren B; Hopkins CR; Lindsley CW; Lin Z; Babcock JJ; McManus OB; Neubig RR
Cell Signal; 2013 Dec; 25(12):2848-55. PubMed ID: 24041654
[TBL] [Abstract][Full Text] [Related]
12. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
[TBL] [Abstract][Full Text] [Related]
13.
Huang MW; Lin YJ; Chang CW; Lei FJ; Ho EP; Liu RS; Shyu WC; Hsieh CH
Theranostics; 2018; 8(17):4781-4794. PubMed ID: 30279737
[No Abstract] [Full Text] [Related]
14. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
15. RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.
Talbot JN; Jutkiewicz EM; Graves SM; Clemans CF; Nicol MR; Mortensen RM; Huang X; Neubig RR; Traynor JR
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11086-91. PubMed ID: 20534514
[TBL] [Abstract][Full Text] [Related]
16. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
17. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
18. RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate.
Wydeven N; Posokhova E; Xia Z; Martemyanov KA; Wickman K
J Biol Chem; 2014 Jan; 289(4):2440-9. PubMed ID: 24318880
[TBL] [Abstract][Full Text] [Related]
19. Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.
Wang Q; Traynor JR
J Biol Chem; 2011 Mar; 286(10):7854-7864. PubMed ID: 21209077
[TBL] [Abstract][Full Text] [Related]
20. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
